Bercedis L. Peterson

15.9k citations
139 papers · 12.0k indexed · 3 hit papers · h-index 55
Topics
Chronic Lymphocytic Leukemia Research (20 papers)Lymphoma Diagnosis and Treatment (15 papers)Cancer survivorship and care (13 papers)

In The Last Decade

Bercedis L. Peterson

137 papers receiving 11.5k citations

Hit Papers

Randomized Controlled Trial of Azacitidine in Patients Wi...19902026200220142002200019904008001.2k

Peers

Bercedis L. Peterson
Comparison fields: 5 of 197
  • Oncology 3.1k
  • Molecular Biology 2.0k
  • Public Health, Environmental and Occupational Health 2.0k
  • Genetics 1.9k
  • Hematology 1.9k
Replace María E. Suarez‐Almazor with:
María E. Suarez‐Almazor United States
Dallas R. English Australia
Jan Sundquist Sweden
Kristina Sundquist Sweden
Richard Gray United Kingdom
Lynn A. G. Ries United States
Paul C. Lambert United Kingdom
Andrea B. Troxel United States
J.C.J.M. de Haes Netherlands
Patricia Hartge United States
Bercedis L. Peterson relative to María E. Suarez‐Almazor United States María E. Suarez‐Almazor's profile →
Citations per field
00.5×1.5×
María E. Suarez‐Almazor · 1×
Citations per year

Countries citing papers authored by Bercedis L. Peterson

Since Specialization
Citations

This map shows the geographic impact of Bercedis L. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bercedis L. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bercedis L. Peterson more than expected).

Fields of papers citing papers by Bercedis L. Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bercedis L. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bercedis L. Peterson. The network helps show where Bercedis L. Peterson may publish in the future.

Co-authorship network of co-authors of Bercedis L. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of Bercedis L. Peterson. A scholar is included among the top collaborators of Bercedis L. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bercedis L. Peterson. Bercedis L. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 26
2 83
3 64
4 102
5 36
6 15
7 60
8 86
9 404
10 45
11 45
12 28
13 153
14 132
15
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemiabreakdown →
754
16 108
17 104
18 462
19 19
20 41

About Bercedis L. Peterson

Bercedis L. Peterson is a scholar working on Genetics, Hematology and Oncology, having authored 139 papers that have together received 12.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (20 papers), Lymphoma Diagnosis and Treatment (15 papers) and Cancer survivorship and care (13 papers). The work is most often cited by research in Genetics (1.9k citations), Hematology (1.9k citations) and Oncology (3.1k citations). Bercedis L. Peterson has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Richard A. Larson, Frank E. Harrell, Wendy Demark‐Wahnefried, Charles A. Schiffer, Colleen M. McBride, Harold G. Koenig, Lewis R. Silverman, Isaac M. Lipkus, James F. Holland and Alice B. Kornblith. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026